Other
Intelligence
14
Pipeline Programs↗
5
Active Trials↗
11
Companies Involved↗
Intelligence is an emerging landscape with 14 programs across 11 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Bayer. 5 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical7
Phase 1
No programs
Phase 21
Approved5
Analysis
Trial Status
18
clinical trials
Completed9 · 50%
Recruiting3 · 17%
Unknown status3 · 17%
Active, not recruiting1 · 6%
Terminated1 · 6%
Not yet recruiting1 · 6%
Clinical Trials
Trial Activity
18 trials
An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis
Recruiting·—·Phase 2·NCT07013110·124 enrolled
A Single-center Cross-sectional Study Comparing Two Image Acquisition Modalities for Second-trimester Pregnancy Screening Ultrasound.
Completed·—·Preclinical·NCT07286591·50 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)